ATC codes:
J01GB06
EMLc
Indication
Sepsis without septic shock
ICD11 code:
1G40
INN
Amikacin
Medicine type
Chemical agent
Antibiotic groups
List type
Core
Formulations
Parenteral > General injections > unspecified:
250 mg per mL in 2 mL vial (as sulfate)
(EMLc)
EML status history
Sex
All
Age
Children (1 month - 12 years)
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Expert Committee recommendation
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of a new strength formulation of amikacin (injection 50 mg/mL (as sulfate) in 2 mL vial) to the EMLc.
- the addition of new formulations of amoxicillin (dispersible, scored tablet, 250 mg and 500 mg) to the EMLc.
- the addition of new strength formulations of cefotaxime (powder for injection: 500 mg; 1 g; 2 g (as sodium) in vial) to the EML and EMLc.
- the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc.
- the addition of new strength formulations of cloxacillin (capsule 250 mg, powder for injection 250 mg (as sodium) and powder for oral liquid 250 mg/5 mL (as sodium) on the EMLc.
EML recommendations: Sepsis without septic shock
First choice
Second choice
First choice
gentamicin
co-prescribed with
amoxicillin
gentamicin co-prescribed with ampicillin
gentamicin co-prescribed with benzylpenicillin
gentamicin co-prescribed with ampicillin
gentamicin co-prescribed with benzylpenicillin
Second choice